Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...

Weight-loss jabs, known as GLP-1 receptor agonists, work by reducing food cravings. The NPA has previously urged patients to ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

Weight-loss drug developer Metsera on Monday said it was is targeting to raise as much as $292.2 million in an initial public offering.

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...

Gypsy-Rose Blanchard is setting the record straight when it comes to rumors circulating about her baby daughter Aurora Raina ...

Gypsy-Rose Blanchard is setting the record straight when it comes to rumors circulating about her baby daughter Aurora Raina ...

Gypsy-Rose Blanchard exclusively told PEOPLE that she is not using weight-loss drugs to lose weight since giving birth to her ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...